Xenotransplantation is the process of transplanting living cells, organs or tissues from animals into humans. …

Remote Patient Monitoring (RPM) solutions can predict, prevent and manage events through continuous remote monitoring. …

The hemocompatibility (blood compatibility) of materials is a major issue in the design of medical devices, particularly artificial hearts. …

Studies show that women die at a systematically higher rate than men when waiting for a donor heart. …

Medtechs and Biotechs are positioning themselves as true drivers of medical innovation. This synergy between technology and medicine is fundamentally transforming the way healthcare is delivered. …

Nantes, France, June 6, 2023 - PROCOPE Medicals, designer of a fully implantable cardiac prosthesis, is proud to announce that it has already reached its minimum target of 400,000 euros in its fundraising campaign launched just 21 days ago. The fundraising is still underway and accessible on the Tudigo participative financing platform. …

In fact, there is as yet no destination therapy enabling patients to live with a heart prosthesis over the long term. …

The hemodynamics of the prosthesis are therefore analyzed by numerical simulation. This is an important part of our study on the biocompatibility and hemocompatibility of the prosthesis. …

The number of patients on waiting lists and the shortage of organs are the main threats to organ transplantation: only 3% of patients receive a donor heart. …

As investors, you can add value to these innovative companies. Becoming a shareholder in a company will enable you to obtain a tax reduction. …

The extent of the shortage means that new, innovative therapeutic options need to be sought, and one of the alternatives being studied is xenotransplantation. …

Nantes, France, October 19, 2022 - PROCOPE Medicals, designer of a fully implantable cardiac prosthesis, has completed the first phase of physical implantations of its artificial heart device. …